Thomas Taynton

636 total citations
3 papers, 46 citations indexed

About

Thomas Taynton is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Thomas Taynton has authored 3 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 0 papers in Organic Chemistry. Recurrent topics in Thomas Taynton's work include Antifungal resistance and susceptibility (2 papers), Fungal Infections and Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Thomas Taynton is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Fungal Infections and Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Thomas Taynton collaborates with scholars based in United Kingdom. Thomas Taynton's co-authors include Gavin Barlow, Peter Moss, Anda Samson, Monica Ivan, Phillipa Burns, Kavitha Gajee, Kirstine Eastick, Patrick Lillie, Kate Adams and Nicholas Easom and has published in prestigious journals such as Influenza and Other Respiratory Viruses, Expert Review of Hematology and JAC-Antimicrobial Resistance.

In The Last Decade

Thomas Taynton

2 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Taynton United Kingdom 2 26 16 13 10 8 3 46
Mohamed Elbahnasawy Egypt 3 60 2.3× 8 0.5× 14 1.1× 12 1.2× 4 0.5× 7 82
Mohamed Samir Abd El Ghafar Egypt 3 60 2.3× 7 0.4× 14 1.1× 8 0.8× 4 0.5× 5 73
Luciene Barra Ribeiro Brazil 2 58 2.2× 9 0.6× 32 2.5× 6 0.6× 4 0.5× 2 79
Ana Paula Figueiredo Guimaraes Almeida Brazil 2 58 2.2× 9 0.6× 32 2.5× 6 0.6× 4 0.5× 2 90
Seán Boyd Ireland 4 23 0.9× 14 0.9× 11 0.8× 4 0.4× 3 0.4× 5 42
Claire Mackintosh United Kingdom 4 20 0.8× 5 0.3× 5 0.4× 5 0.5× 6 0.8× 5 44
Matteo Chiurlo Italy 4 55 2.1× 27 1.7× 7 0.5× 12 1.2× 2 0.3× 9 72
Sin Young Ham South Korea 4 47 1.8× 13 0.8× 20 1.5× 2 0.2× 6 0.8× 13 77
Anum Rahim Pakistan 5 21 0.8× 9 0.6× 7 0.5× 6 0.6× 3 0.4× 15 61
Süha Bozbay Türkiye 4 6 0.2× 7 0.4× 13 1.0× 10 1.0× 7 0.9× 7 50

Countries citing papers authored by Thomas Taynton

Since Specialization
Citations

This map shows the geographic impact of Thomas Taynton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Taynton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Taynton more than expected).

Fields of papers citing papers by Thomas Taynton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Taynton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Taynton. The network helps show where Thomas Taynton may publish in the future.

Co-authorship network of co-authors of Thomas Taynton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Taynton. A scholar is included among the top collaborators of Thomas Taynton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Taynton. Thomas Taynton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Taynton, Thomas, David Allsup, & Gavin Barlow. (2024). How can we optimize antifungal use and stewardship in the treatment of acute leukemia?. Expert Review of Hematology. 17(9). 581–593.
2.
Taynton, Thomas, Gavin Barlow, & David Allsup. (2022). PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia. JAC-Antimicrobial Resistance. 4(4). dlac074–dlac074. 2 indexed citations
3.
Easom, Nicholas, Peter Moss, Gavin Barlow, et al.. (2020). Sixty‐eight consecutive patients assessed for COVID‐19 infection: Experience from a UK Regional infectious diseases Unit. Influenza and Other Respiratory Viruses. 14(4). 374–379. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026